Cargando…

Characterization of Pharmaceutical Tablets Using UV Hyperspectral Imaging as a Rapid In-Line Analysis Tool

A laboratory prototype for hyperspectral imaging in ultra-violet (UV) region from 225 to 400 nm was developed and used to rapidly characterize active pharmaceutical ingredients (API) in tablets. The APIs are ibuprofen (IBU), acetylsalicylic acid (ASA) and paracetamol (PAR). Two sample sets were used...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Ktash, Mohammad, Stefanakis, Mona, Boldrini, Barbara, Ostertag, Edwin, Brecht, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271527/
https://www.ncbi.nlm.nih.gov/pubmed/34203526
http://dx.doi.org/10.3390/s21134436
_version_ 1783721023394283520
author Al Ktash, Mohammad
Stefanakis, Mona
Boldrini, Barbara
Ostertag, Edwin
Brecht, Marc
author_facet Al Ktash, Mohammad
Stefanakis, Mona
Boldrini, Barbara
Ostertag, Edwin
Brecht, Marc
author_sort Al Ktash, Mohammad
collection PubMed
description A laboratory prototype for hyperspectral imaging in ultra-violet (UV) region from 225 to 400 nm was developed and used to rapidly characterize active pharmaceutical ingredients (API) in tablets. The APIs are ibuprofen (IBU), acetylsalicylic acid (ASA) and paracetamol (PAR). Two sample sets were used for a comparison purpose. Sample set one comprises tablets of 100% API and sample set two consists of commercially available painkiller tablets. Reference measurements were performed on the pure APIs in liquid solutions (transmission) and in solid phase (reflection) using a commercial UV spectrometer. The spectroscopic part of the prototype is based on a pushbroom imager that contains a spectrograph and charge-coupled device (CCD) camera. The tablets were scanned on a conveyor belt that is positioned inside a tunnel made of polytetrafluoroethylene (PTFE) in order to increase the homogeneity of illumination at the sample position. Principal component analysis (PCA) was used to differentiate the hyperspectral data of the drug samples. The first two PCs are sufficient to completely separate all samples. The rugged design of the prototype opens new possibilities for further development of this technique towards real large-scale application.
format Online
Article
Text
id pubmed-8271527
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82715272021-07-11 Characterization of Pharmaceutical Tablets Using UV Hyperspectral Imaging as a Rapid In-Line Analysis Tool Al Ktash, Mohammad Stefanakis, Mona Boldrini, Barbara Ostertag, Edwin Brecht, Marc Sensors (Basel) Article A laboratory prototype for hyperspectral imaging in ultra-violet (UV) region from 225 to 400 nm was developed and used to rapidly characterize active pharmaceutical ingredients (API) in tablets. The APIs are ibuprofen (IBU), acetylsalicylic acid (ASA) and paracetamol (PAR). Two sample sets were used for a comparison purpose. Sample set one comprises tablets of 100% API and sample set two consists of commercially available painkiller tablets. Reference measurements were performed on the pure APIs in liquid solutions (transmission) and in solid phase (reflection) using a commercial UV spectrometer. The spectroscopic part of the prototype is based on a pushbroom imager that contains a spectrograph and charge-coupled device (CCD) camera. The tablets were scanned on a conveyor belt that is positioned inside a tunnel made of polytetrafluoroethylene (PTFE) in order to increase the homogeneity of illumination at the sample position. Principal component analysis (PCA) was used to differentiate the hyperspectral data of the drug samples. The first two PCs are sufficient to completely separate all samples. The rugged design of the prototype opens new possibilities for further development of this technique towards real large-scale application. MDPI 2021-06-28 /pmc/articles/PMC8271527/ /pubmed/34203526 http://dx.doi.org/10.3390/s21134436 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Al Ktash, Mohammad
Stefanakis, Mona
Boldrini, Barbara
Ostertag, Edwin
Brecht, Marc
Characterization of Pharmaceutical Tablets Using UV Hyperspectral Imaging as a Rapid In-Line Analysis Tool
title Characterization of Pharmaceutical Tablets Using UV Hyperspectral Imaging as a Rapid In-Line Analysis Tool
title_full Characterization of Pharmaceutical Tablets Using UV Hyperspectral Imaging as a Rapid In-Line Analysis Tool
title_fullStr Characterization of Pharmaceutical Tablets Using UV Hyperspectral Imaging as a Rapid In-Line Analysis Tool
title_full_unstemmed Characterization of Pharmaceutical Tablets Using UV Hyperspectral Imaging as a Rapid In-Line Analysis Tool
title_short Characterization of Pharmaceutical Tablets Using UV Hyperspectral Imaging as a Rapid In-Line Analysis Tool
title_sort characterization of pharmaceutical tablets using uv hyperspectral imaging as a rapid in-line analysis tool
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271527/
https://www.ncbi.nlm.nih.gov/pubmed/34203526
http://dx.doi.org/10.3390/s21134436
work_keys_str_mv AT alktashmohammad characterizationofpharmaceuticaltabletsusinguvhyperspectralimagingasarapidinlineanalysistool
AT stefanakismona characterizationofpharmaceuticaltabletsusinguvhyperspectralimagingasarapidinlineanalysistool
AT boldrinibarbara characterizationofpharmaceuticaltabletsusinguvhyperspectralimagingasarapidinlineanalysistool
AT ostertagedwin characterizationofpharmaceuticaltabletsusinguvhyperspectralimagingasarapidinlineanalysistool
AT brechtmarc characterizationofpharmaceuticaltabletsusinguvhyperspectralimagingasarapidinlineanalysistool